Servier is a global pharma company that has commercialized more than 50 molecules over the last 60 years. We are selling our products in 140+ countries and we invest, each year, 25% of the turnover in innovation and R&D. The business unit “Servier CDMO” was created to bring this expertise to the companies looking for quality, reliability and flexibility in their projects. We can cover all the phases from the clinical supply to the manufacturing for drug substance and drug product. The network of 11 facilities across the world with a reliable supply chain can deliver to the partner the benefit of our experience and resources.